The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(E)-(R)-4-((2R,4bS,7S,8aR)-7-Hydroxy-2,4b-dimethyl-1-oxo-tetradecahydro-phenanthren-2-yl)-hex-2-enoic acid 2-dimethylamino-ethyl ester ID: ALA321090
PubChem CID: 44334168
Max Phase: Preclinical
Molecular Formula: C26H43NO4
Molecular Weight: 433.63
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CC[C@H](/C=C/C(=O)OCCN(C)C)[C@@]1(C)CCC2C(CC[C@@H]3C[C@@H](O)CC[C@]23C)C1=O
Standard InChI: InChI=1S/C26H43NO4/c1-6-18(8-10-23(29)31-16-15-27(4)5)26(3)14-12-22-21(24(26)30)9-7-19-17-20(28)11-13-25(19,22)2/h8,10,18-22,28H,6-7,9,11-17H2,1-5H3/b10-8+/t18-,19-,20+,21?,22?,25+,26-/m1/s1
Standard InChI Key: IJRWRMFNPYXLPH-ACVHBDGZSA-N
Molfile:
RDKit 2D
32 34 0 0 1 0 0 0 0 0999 V2000
4.5750 -7.4250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1292 -7.1292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0917 -7.1250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1375 -6.5292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6125 -7.4250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5750 -8.0250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6167 -6.2250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0917 -6.5250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0500 -7.1250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9042 -5.7875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6042 -8.0250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4917 -5.6667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6875 -5.1000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7000 -7.3250 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.7125 -6.3500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0875 -8.3250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0500 -8.3250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2875 -4.6500 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.5375 -7.4250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2417 -3.7250 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.2750 -4.9792 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.5375 -8.0250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5667 -6.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1375 -5.9292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4625 -4.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0167 -8.3167 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.0500 -4.2917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0625 -6.8417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8375 -3.6125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8500 -3.2792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6625 -6.8417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7250 -8.7625 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
2 5 1 0
3 1 1 0
4 7 1 0
5 3 1 0
6 1 1 0
7 8 1 0
8 3 1 0
9 1 1 0
15 10 1 1
11 16 1 0
12 10 2 0
13 12 1 0
14 2 2 0
15 4 1 0
16 6 1 0
17 6 1 0
18 13 2 0
19 9 1 0
20 27 1 0
21 13 1 0
22 19 1 0
1 23 1 1
4 24 1 1
25 21 1 0
22 26 1 1
27 25 1 0
28 15 1 0
29 20 1 0
30 20 1 0
31 28 1 0
6 32 1 1
22 17 1 0
5 11 1 0
2 4 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 433.63Molecular Weight (Monoisotopic): 433.3192AlogP: 4.24#Rotatable Bonds: 7Polar Surface Area: 66.84Molecular Species: NEUTRALHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 7.72CX LogP: 4.90CX LogD: 4.41Aromatic Rings: ┄Heavy Atoms: 31QED Weighted: 0.48Np Likeness Score: 1.66
References 1. De Munari S, Barassi P, Cerri A, Fedrizzi G, Gobbini M, Mabilia M, Melloni P.. (1998) A new approach to the design of novel inhibitors of Na+,K+-ATPase: 17alpha-substituted seco-D 5beta-androstane as cassaine analogues., 41 (16): [PMID:9685243 ] [10.1021/jm980108d ] 2. Gobbini M, Barassi P, Cerri A, De Munari S, Fedrizzi G, Santagostino M, Schiavone A, Torri M, Melloni P.. (2001) 17 alpha-O-(aminoalkyl)oxime derivatives of 3 beta,14 beta-dihydroxy-5 beta-androstane and 3 beta-hydroxy-14-oxoseco-D-5 beta-androstane as inhibitors of Na(+),K(+)-ATPase at the digitalis receptor., 44 (23): [PMID:11689068 ] [10.1021/jm0109208 ]